Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05327621 | Pamiparib in mCRPC With HRD or BRCA1/2 Mutation | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT05319145 | PeRsonalizing the Approach to the Oncologic Frail Individual Through Tailored Assessment and Intervention (PROFIT Study)(PROFIT) | unknown | N/A | 268 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 2 | Apr 13, 2022 |
| clinicaltrials |
| NCT04773821 | Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy(IRMProft) | unknown | N/A | 260 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 29, 2022 | clinicaltrials |
| NCT03238170 | MR-simulation in Radiotherapy for Prostate Cancer(FIMRA-P) | unknown | N/A | 40 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT05286840 | 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer | unknown | Phase 1 / Phase 2 | 150 | Luke Nordquist, MDOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT05212857 | Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer | unknown | Phase 2 | 160 | Fudan UniversityOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT05077852 | Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder | unknown | — | 194 | Ankara Training and Research HospitalOTHER | 1 | Mar 15, 2022 | clinicaltrials |
| NCT02994758 | Development of Diagnostics and Treatment of Urological Cancers(DEDUCER) | unknown | N/A | 100 | Helsinki University Central HospitalOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05192694 | Evaluation of Fapi-pet in Prostate Cancer.(FAPIPETPCA) | unknown | N/A | 40 | Helsinki University Central HospitalOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT02563691 | Stereotactic Radiotherapy for Oligometastatic Prostate Cancer(CROP) | unknown | Phase 1 / Phase 2 | 90 | Sunnybrook Health Sciences CentreOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT03061643 | An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma | unknown | Phase 2 | 42 | Samsung Medical CenterOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT03526510 | Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate Cancer | unknown | N/A | 178 | Dr. Patrick CheungOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT03572621 | Development and Evaluation of a Therapeutic Education Intervention in Prostate Cancer Patients Treated With Radical Prostatectomy to Improve Their Sexuality(PRODUCAN) | unknown | N/A | 240 | Hospices Civils de LyonOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT05262608 | The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation(PROspect) | unknown | Phase 2 | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05248282 | Clinical Validation of the Prognostic Value of the PrTS on Prostate Cancer Patients | unknown | — | 150 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Feb 21, 2022 | clinicaltrials |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 340 | Tarveda TherapeuticsINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
| NCT05224024 | Retzius-sparing Technique in Robotic-assisted Radical Prostatectomy | unknown | N/A | 80 | Ankara UniversityOTHER | 1 | Feb 4, 2022 | clinicaltrials |
| NCT05187026 | Electrical Patient Reported Outcome of Prostate Cancer RadioTherapy(ePRO-PCaRT) | unknown | — | 300 | Helsinki University Central HospitalOTHER | 1 | Jan 26, 2022 | clinicaltrials |
| NCT05188911 | Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial | unknown | — | 30 | Fudan UniversityOTHER | 1 | Jan 12, 2022 | clinicaltrials |
| NCT05180305 | A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening | unknown | — | 200 | TSH Biopharm Corporation LimitedINDUSTRY | 1 | Jan 6, 2022 | clinicaltrials |
| NCT05179694 | The TRANSLATE Trial(TRANSLATE) | unknown | N/A | 1,042 | University of OxfordOTHER | 1 | Jan 5, 2022 | clinicaltrials |
| NCT05156424 | A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer | unknown | Phase 1 / Phase 2 | 24 | Kira MurphyOTHER | 1 | Dec 14, 2021 | clinicaltrials |
| NCT05156450 | TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer | unknown | Phase 2 | 30 | West China HospitalOTHER | 1 | Dec 14, 2021 | clinicaltrials |
| NCT04831307 | 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical | unknown | N/A | 10 | British Columbia Cancer AgencyOTHER | 1 | Dec 3, 2021 | clinicaltrials |
| NCT02739659 | Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer | unknown | N/A | 73 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Nov 19, 2021 | clinicaltrials |
| NCT04724577 | 12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer | unknown | N/A | 30 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Nov 19, 2021 | clinicaltrials |
| NCT05106699 | Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases | unknown | N/A | 54 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Nov 4, 2021 | clinicaltrials |
| NCT05060835 | ONCOlogy-targeted NLP-powered Federated Hyper-archItecture and Data Sharing Framework for Health Data Reusability(ONCO-FIRE) | unknown | — | 5,000 | Instituto de Investigacion Sanitaria La FeOTHER | 0 | Oct 29, 2021 | clinicaltrials |
| NCT05073653 | A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer | unknown | N/A | 80 | Xiangya Hospital of Central South UniversityOTHER | 1 | Oct 19, 2021 | clinicaltrials |
| NCT01562223 | Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer(A6701QIBA) | unknown | N/A | 30 | American College of Radiology Imaging NetworkNETWORK | 1 | Oct 18, 2021 | clinicaltrials |
| NCT05068180 | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | unknown | Phase 4 | 200 | RenJi HospitalOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT04851639 | The Wolverhampton Assessment Tool, a Tool for Patient-reported Wellbeing in the Context of Prostate Cancer(WATapp) | unknown | N/A | 50 | University of WolverhamptonOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT04846894 | Ga-68 PSMA-11 PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: Digital PET/CT Versus Analog PET/CT | unknown | N/A | 43 | Jin-Sook RyuOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT04167722 | How Does Prostate Cancer Metastasize? Studying the Role of Secreted Packages (Exosomes) From Fat Tissue in Lean and Obese Patients(EXOPRO) | unknown | — | 100 | Imperial College LondonOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04379362 | MRI-guided Focal Laser Ablation(Unicorn) | unknown | Phase 2 | 53 | Radboud University Medical CenterOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT05044754 | SCAP vs HIFU for Recurrent Prostate Cancer After Radiation Therapy(SALVPROST) | unknown | — | 50 | University Hospital Virgen de las NievesOTHER | 2 | Sep 16, 2021 | clinicaltrials |
| NCT03305224 | The Combination Therapy With Ra-223 and Enzalutamide(CORE-OCU) | unknown | Phase 2 | 10 | Taro Iguchi, MD, PHDOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04228055 | Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)(CLIPP2) | unknown | N/A | 36 | University of ArizonaOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT03040791 | Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)(ImmunoProst) | unknown | Phase 2 | 38 | Hospital Moinhos de VentoOTHER | 1 | Aug 26, 2021 | clinicaltrials |
| NCT05021952 | Postoperative Prognosis Management Service Based mHealth for Prostate Cancer Patients | unknown | N/A | 324 | Seoul St. Mary's HospitalOTHER | 1 | Aug 26, 2021 | clinicaltrials |
| NCT05022160 | Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve Block | unknown | Early Phase 1 | 250 | Armed Forces Hospital, PakistanOTHER | 1 | Aug 26, 2021 | clinicaltrials |
| NCT03050866 | Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)(CABA-V7) | unknown | Phase 2 | 140 | Erasmus Medical CenterOTHER | 1 | Aug 20, 2021 | clinicaltrials |
| NCT03119857 | Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14 | unknown | Phase 3 | 349 | Göteborg UniversityOTHER | 4 | Aug 18, 2021 | clinicaltrials |
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04985110 | Administration of Antibiotic Prophylaxis for Transperineal Prostate Biopsy in Cipto Mangunkusumo Hospital | unknown | Phase 2 | 78 | Indonesia UniversityOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT04177056 | Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief(SOLAR-P) | unknown | N/A | 40 | Hamilton Health Sciences CorporationOTHER | 1 | Aug 2, 2021 | clinicaltrials |
| NCT04983706 | Optimization of the Core Number and Location for Targeted Prostate Biopsy | unknown | N/A | 100 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jul 30, 2021 | clinicaltrials |
| NCT04984395 | Improving Diagnosis and Treatment of Metastatic Advanced Prostate Cancer(IDT) | unknown | — | 50 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jul 30, 2021 | clinicaltrials |
| NCT04248621 | Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients | unknown | Phase 4 | 164 | Wonju Severance Christian HospitalOTHER | 1 | Jul 29, 2021 | clinicaltrials |
| NCT04982536 | Assessment of VMCore Biopsy Versus Standard of Care Biopsy | unknown | N/A | 40 | Uro-1 MedicalINDUSTRY | 1 | Jul 29, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Apr 14, 2022source: clinicaltrials